Welcome to our dedicated page for APTARGROUP SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
AptarGroup, Inc. President and CEO Stephan B. Tanda exercised stock options covering 9,838 shares at an exercise price of $74.79 per share and on August 3, 2026 sold 9,838 common shares at a weighted average $136.1647 (range $136.00–$136.52). He continues to hold 3,150 shares indirectly through a 401(k) trust.
Aptargroup, Inc. has a filing from shareholder Marc Prieur indicating an intention to sell up to 3,500 common shares of Aptargroup held through UBS Switzerland AG, listed on the NYSE. The proposed sale is tied to equity awards granted as RSUs and PSUs on March 14, 2022.
The disclosure also notes that 5,000 common shares of Aptargroup were sold on June 9, 2026 for approximately $577,894.00. The planned 3,500-share sale is shown with an approximate value of $476,000.00.
APTARGROUP, INC. Segment President Hedi Tlili sold 8,854 shares of Common Stock on August 3, 2026 at $135.00 per share in an open market or private transaction. Following this sale, he directly owns 15,379 shares. The trade was not made under a Rule 10b5-1 plan.
ATR has a selling security holder planning to dispose of up to 8,855 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on the NYSE and a proposed sale date of 08/03/2026. The shares come from restricted stock that vested under a registered plan in connection with services rendered. Vesting events include 3,604 shares on 05/02/2025, 3,598 shares on 05/01/2026, and several smaller grants on dates in 2025 and 2026.
APTARGROUP, INC. director George L. Fotiades received a grant of 151 shares of Common Stock on July 16, 2026. The shares were acquired at $0.00 per share as an award, bringing his directly held position to 6,446 shares following the transaction.
Kampouri Monnas Giovanna reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. director Giovanna Kampouri Monnas received an equity award of 151 shares of Common Stock on 2026-07-16 at no cost, increasing her directly held stake to 10,128 shares.
AptarGroup, Inc. director Isabel Marey-Semper received a grant of 151 shares of Common Stock on 2026-07-16, reported as a grant/award acquisition at a per-share price of $0.0000. Following this award, she directly owns 9,821 shares of AptarGroup common stock.